Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.

[1]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[2]  T. Kadowaki,et al.  Selective purification and characterization of adiponectin multimer species from human plasma. , 2007, Biochemical and biophysical research communications.

[3]  K. Kos,et al.  Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[5]  K. Kos,et al.  Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum , 2007, Diabetologia.

[6]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[7]  B. Xue,et al.  AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues , 2006, The Journal of physiology.

[8]  P. Scherer.  Adipose Tissue , 2006, Diabetes.

[9]  T. Noda,et al.  Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways* , 2006, Journal of Biological Chemistry.

[10]  N. Ruderman,et al.  Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists* , 2006, Journal of Biological Chemistry.

[11]  Ki-Up Lee,et al.  Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis , 2005, Journal of Molecular Medicine.

[12]  N. Ruderman,et al.  AMPK, the metabolic syndrome and cancer. , 2005, Trends in pharmacological sciences.

[13]  D. Porte,et al.  Diabetes, Obesity, and the Brain , 2005, Science.

[14]  D. Hardie.  The AMP-activated protein kinase pathway – new players upstream and downstream , 2004, Journal of Cell Science.

[15]  R. Ahima,et al.  Adiponectin acts in the brain to decrease body weight , 2004, Nature Medicine.

[16]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[17]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[18]  C. Kahn,et al.  Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. , 2003, The Journal of clinical investigation.

[19]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[20]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[21]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[22]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[23]  L. Cornivelli,et al.  Multiple Regulatory Roles of a Novel Saccharomyces cerevisiae Protein, Encoded by YOL002c, in Lipid and Phosphate Metabolism* , 2002, The Journal of Biological Chemistry.

[24]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[25]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[26]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[27]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[28]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Kahn.  Triglycerides and toggling the tummy , 2000, Nature Genetics.

[30]  B. Zlokovic,et al.  Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. , 2000, Endocrinology.

[31]  Satoshi Tanaka,et al.  PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .

[32]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[33]  S. Lightman,et al.  S–100 Antigen‐Positive Folliculostellate Cells are not the Source of IL‐6 Gene Expression in Human Pituitary Adenomas , 1995, Journal of neuroendocrinology.

[34]  W. Banks,et al.  Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. , 2006, Diabetes.

[35]  D. Carling.  AMP-activated protein kinase: balancing the scales. , 2005, Biochimie.

[36]  S. Aizawa,et al.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. , 1999, Molecular cell.